Table 2.
Incidence and Risks for Outcomes of Interest Between Patients With PA and Their EH Matches for the Whole PA Cohort and the APA Subgroup Only
| ESRD (EH vs PA) | Events | Person-(y) | Incidence Rate[per 1000 Person-(y)] | Events | Person-(y) | Incidence Rate [per 1000 Person-(y)] | Crude Hazard Ratio (95% CI) | P | Adjusted Hazard Ratio (95% CI) | P | Competing Hazard Ratio (95% CI) | P |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EH | PA | EH vs PA | ||||||||||
| ESRD | 322 | 55,139.4 | 5.8 | 80 | 14,532.3 | 5.5 | 0.96 (0.75, 1.23) | 0.742 | 0.93 (0.73, 1.19) | 0.571 | 0.96 [0.75, 1.22] | 0.730 |
| Mortality | 1641 | 56,429.2 | 29.1 | 366 | 14,751.6 | 24.8 | 0.86 (0.77, 0.96) | 0.009 | 0.86 (0.77, 0.96) | 0.010 | NA | NA |
| ESRD + mortality | 1811 | 55,139.4 | 32.8 | 421 | 14,532.4 | 29.0 | 0.89 (0.80, 0.99) | 0.035 | 0.89 (0.80, 0.99) | 0.031 | NA | NA |
| EH | APA | EH vs APA | ||||||||||
| ESRD | 84 | 17,670.8 | 4.8 | 11 | 4887.5 | 2.3 | 0.49 (0.26, 0.91) | 0.025 | 0.49 (0.26, 0.91) | 0.025 | 0.50 [0.27, 0.94] | 0.031 |
| Mortality | 375 | 18,055.1 | 20.8 | 40 | 4918.8 | 8.1 | 0.40 (0.29, 0.55) | <0.001 | 0.40 (0.29, 0.55) | <0.001 | NA | NA |
| ESRD + mortality | 421 | 17,670.8 | 23.8 | 49 | 4887.5 | 10.0 | 0.43 (0.32, 0.58) | <0.001 | 0.43 (0.32, 0.58) | <0.001 | NA | NA |
Abbreviation: NA; not available.